Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
28.75
+0.17 (0.59%)
Sep 22, 2026, 4:00 PM EDT - Market closed
PBPH Holdings Information
PBPH is an equity ETF with a total of 62 individual holdings. The top holdings are Eli Lilly and Company stock at 15.26%, Johnson & Johnson at 10.07%, AbbVie at 7.25%, Merck & Co. at 5.72%, and Roche Holding AG at 4.89%.
Total Holdings
62
Top 10 Percentage
63.24%
Asset Class
Equity
ETF Category
Health
Assets
1.03B
PE Ratio
21.52
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 15.26% |
| 2 | JNJ | Johnson & Johnson | 10.07% |
| 3 | ABBV | AbbVie Inc. | 7.25% |
| 4 | MRK | Merck & Co., Inc. | 5.72% |
| 5 | SWX: ROP | Roche Holding AG | 4.89% |
| 6 | LON: AZN | AstraZeneca PLC | 4.69% |
| 7 | AMGN | Amgen Inc. | 4.05% |
| 8 | SWX: NOVN | Novartis AG | 3.99% |
| 9 | GILD | Gilead Sciences, Inc. | 3.96% |
| 10 | PFE | Pfizer Inc. | 3.35% |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | 2.74% |
| 12 | BMY | Bristol-Myers Squibb Company | 2.71% |
| 13 | CPH: NOVO.B | Novo Nordisk A/S | 2.70% |
| 14 | LON: GSK | GSK plc | 2.02% |
| 15 | EPA: SAN | Sanofi | 1.96% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.68% |
| 17 | EBR: ARGX | argenx SE | 1.32% |
| 18 | ASX: CSL | CSL Limited | 1.29% |
| 19 | MRNA | Moderna, Inc. | 1.29% |
| 20 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.25% |
| 21 | ETR: BAYN | Bayer Aktiengesellschaft | 1.18% |
| 22 | NTRA | Natera, Inc. | 1.06% |
| 23 | n/a | Great British Pound | 1.03% |
| 24 | n/a | U.S. Dollar | 0.99% |
| 25 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 0.98% |
As of Sep 21, 2026